Reversion of uroepithelial cell tumorigenesis by the ectopic expression of human wnt-5a

Cell Growth and Differentiation

Volumn 8, Issue 4, 1997, Pages 417-423

  Olson, Daniel J ^a,c   Gibo, Denise M ^a   Saggers, Gregory ^a   Debinski, Waldemar ^d   Kumar, Rakesh ^b,e  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CHROMOSOME 3P; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UROTHELIUM;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 3; GENE DELETION; HUMANS; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; WNT PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0030905786     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ponder, B. Gene losses in human tumors. Nature (Lond.), 335: 400-402, 1988.
2. Ehlen, T., and Dubeau, L. Loss of heterozygosity on chromosomal segments 3p, 6q, and 11p in human ovarian cancers. Oncogene, 5: 219-223, 1990.
3. Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sugimura, T., and Terada, M. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res., 49: 3598-3601, 1989.
4. Brauch, H., Tory, K., Kotler, F., Gazdar, A. F., Pettengill, O. S., Johnson, B., Graziano, S., Winton, T., Buys, C. H. C. M., Sorenson, G. D., Poiesz, B. J., Minna, J. D., and Zbar, B. Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes Chromosomes & Cancer, 1: 240-246, 1990.
5. Heo, D. S., Snyderman, C., Gollin, S. M., Pan, S., Walker, E., Deka, R., Barnes, E. L., and Johnson, A. F. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res., 49: 5167-5175, 1989.
6. Chen, L-C., Matsumura, K., Deng, G., Kurisu, W., Ljung, B-M., Lerman, M. I., Waldman, F. M., and Smith, H. S. Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res., 54: 3021-3024, 1994.
7. Zbar, B., Brauch, H., Talmadge, C., and Linehan, M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.), 327: 721-724, 1987.
8. Yoshida, M. A., Ohyashiki, K., Ochi, H., Gibas, Z., Pontes, J. E., Prout, G. R., Haben, R., and Sandberg, A. A. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res., 46: 2139-2147, 1986.
9. Kok, K., Osinga, J., Carritt, B., Davis, M. B.. van der Hout, A. H., van der Veen, A. Y., Landsvater, R. M., de Leij, L. F. M. H., Berendsen, H. H., Postmus, P. E., Poppema, S., and Buys, C. H. C. M. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (Lond.), 330: 578-581, 1987.
10. Yamakawa, K., Morita, R., Takahashi, E., Hori, T., Ishakawa, J., and Nakamura, Y. A detailed mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res., 51: 4707-4711, 1991.
11. Sanchez, Y., el-Naggar, A., Pathak, S., and Killary, A. M. A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo. Proc. Natl. Acad. Sci. USA, 97: 3383-3387, 1994.
12. Presti, J. C., Reuter, V. E., Galan, T., Fair, W. R., and Cordon-Cardo, C. Molecular genetic alterations in superficial and locally advanced bladder cancer. Cancer Res., 51: 5404-5409, 1991.
13. Clark, C. C., Cohen, I., Eichstetter, I., Cannizzaro, L. A., McPherson, J. D., Wasmuth, J. J., and Iozzo, R. V. Molecular cloning of the human proto-oncogene wnt-5a and mapping of the gene (wnt-5a) to chromosome 3p14-p21. Genomics, 18: 249-260, 1993.
14. Yoshida, M. A., Shimizu, M., Ikeuchi, T., Tonomura, A., Yokota, J., and Oshimura, M. In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion. Mol. Carcinog., 9: 114-121, 1994.
15. Nusse, R., and Varmus, H. E. Wnt genes. Cell, 69: 1073-1087, 1992.
16. Olson, D. J., and Papkoff, J. L. Regulated expression of wnt family members during proliferation of C57MG mammary cells. Cell Growth & Differ., 5: 197-206, 1994.
17. Klingelhutz, A. J., Wu, S-Q., Bookland, E., and Reznikoff, C. A. Allelic 3p deletions in high-grade carcinomas after transformation in vitro of human uroepithelial cells. Genes Chromosomes & Cancer, 3: 346-357, 1991.
18. Wu, S-Q., Storer, B. E., Bookland, E. A., Klingelhutz, A. J., Gilchrist, K. W., Meisner, L. F., Oyasu, R., and Reznikoff, C. A. Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells. Cancer Res., 57: 3323-3326, 1991.
19. Klingelhutz, A. J., Wu, S-Q., Huang, J., and Reznikoff, C. A. Loss of 3p13-p21.2 in tumorigenic reversion of a hybrid between isogeneic non-tumorigenic and tumorigenic human uroepithelial cells. Cancer Res., 52: 1631-1634, 1992.
20. Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E., and DeLange, T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol., 16: 3765-3772, 1996.
21. Sharma, H. W., Sokoloski, J. A., Perez, J. R., Maltese, J. Y., Sartorelli, A. C., Stein, C. A., Nichols, G., Khaled, Z., Telang, N. T., and Narayanan, R. Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA, 92: 12343-12346, 1995.
22. Lejeune, S., Huguet, E. L., Hamby, A., Poulsom, R., and Harris, A. L. Wnt-5a cloning, expression, and up-regulation in human primary breast cancers. Clin. Cancer Res., 1: 215-222, 1995.
23. Iozzo, R. V., Eichstetter, I., and Danielson, K. G. Aberrant expression of the growth factor wnt-5a in human malignancy. Cancer Res., 55: 3495-3499, 1995.
24. Christian, B. J., Loretz, L. J., Oberley, T. D., and Reznikoff, C. A. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res., 407: 6066-6073, 1987.
25. Huguet, E. L., Smith, K., Bicknell, R., and Harris, A. L. Regulation of wnt-5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor. J. Biol. Chem., 270: 12851-12856, 1995.
26. Moon, R. T., Campbell, R. M., Christian, J. L., McGrew, L. L., Shih, J., and Fraser, S. Xwnt-5a: a maternal wnt that affects morphogenetic movements after overexpression in embryos of Xenopus Laevis. Development, 119: 97-111, 1993.
27. Moon, R. T., DeMarais, A. A., and Olson, D. J. Responses to wnt signals in vertebrate embryos may induce changes in cell adhesion and cell movement. J. Cell Sci., 77 (Suppl.): 183-188, 1993.
28. Torres, M. A., Yang-Snyder, J. A., Purcell, S. M., DeMarais, A. A., McGrew, L. L., and Moon, R. T. Activities of the wnt-1 class of secreted signaling factors are antagonized by the wnt-5a class and by a dominant negative cadherin in early Xenopus development. J. Cell Biol., 133: 1123-1137, 1996.
29. Kintner, C. Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain. Cell, 69: 225-236, 1992.
30. Tuszynski, G. P., and Nicosia, R. F. The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays, 18: 71-76, 1996.
31. Greider, C. W. Telomerase biochemistry and regulation. In: E. H. Blackburn and C. W. Greider (eds.), Telomeres, pp. 35-69. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1995.
32. Harley, C. B., and Villeponteau, B. Telomere and telomerase in aging and cancer. Curr. Opin. Genet. Dev., 5: 249-255, 1995.
33. Counter, C. M., Avilian, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
34. Greider, C. W., Blasco, M., Buchkovich, K., Rizen, M., and Hanahan, D. Mouse models of telomerase regulation. In: International Workshop on Telomerase Activity and Early Detection of Cancer, pp. 37-38. National Cancer Institute, 1996.
35. Zhu, X., Kumar, R., Mandal, M., Sharma, N., Sharma, H. W., Dhingra, U., Sokoloski, J. A., Hsiao, R., and Narayanan, R. Cell-cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. USA, 93: 6091-6095, 1996.
36. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyante-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
37. Debinski, W., Karisson, B., Lindholm, L., Siegall, C. B., Willingham, M. C., Fitzgerald, D., and Pastan, I. Monoclonal antibody c242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice. J. Clin. Invest., 90: 405-411, 1992.
38. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.